United States Antimony Corporation (UAMY) Guidance & Earnings Results

On 2026-08-17 United States Antimony Corporation mixed guidance: "Q3 2026 expected revenue from DLA deliveries: $2.6M; Q4 2026 expected cash flow from DLA deliveries: ~$4M; cumulative DLA orders $57.3M; four grant applications totaling $275M…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

UAMYUnited States Antimony CorporationFollow UAMY — free

Other Industrial Metals & Mining · Basic Materials

—

Price chart with a free account

Market cap: 458.0M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 18 Nov, in 25 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
17 Aug 26	Mixed	Q3 2026 expected revenue from DLA deliveries: $2.6M; Q4 2026 expected cash flow from DLA deliveries: ~$4M; cumulative DLA orders $57.3M; four grant applications totaling $275M pending.
15 May 26	Reaffirmed	Full-year 2026 gross revenue guidance of $125 million · full year
14 May 26	Reaffirmed	Full-year 2026 gross revenue guidance of $125 million · full year
19 Mar 26	Reaffirmed	FY2026 gross revenue guidance of $125 million · full year
14 Nov 25	Mixed	Q4 margin pressure from declining antimony prices; offset by long-term contracts and volume increase.
12 Nov 25	Raised	FY2025 revenue $40-43M (narrowed); FY2026 revenue $125M (reiterated) · full year
15 Aug 25	Reaffirmed	$40-50M revenue for FY2025 · full year
12 Aug 25	Reaffirmed	FY2025 revenue guidance of $40 to $50 million · full year

United States Antimony Corporation — questions

What guidance did United States Antimony Corporation give?: On 2026-08-17: "Q3 2026 expected revenue from DLA deliveries: $2.6M; Q4 2026 expected cash flow from DLA deliveries: ~$4M; cumulative DLA orders $57.3M; four grant applications totaling $275M pending."
When does United States Antimony Corporation report earnings?: United States Antimony Corporation's next earnings report is expected on 2026-11-18.

Every figure on this page comes from United States Antimony Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.